Trial
NCT02003573
Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Leukemia, Myeloid, Acute
Intervention
decitabine iv
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-31